In the immediate vaccine model, CD24-Fc or human IgG-Fc control was injected simultaneously with the whole cell vaccine plus anti-PD-L1/CTLA4 antibodies at day 7, 10 and 13 post tumor inoculation (Figure 5A). The gene discussed is CTLA4; the disease is neoplasm.